跳至主要内容
临床试验/CTRI/2008/091/000280
CTRI/2008/091/000280已完成4 期

A double blind comparative randomized study evaluating the efficacy and safety of combined application of topical diltiazem and lignocaine as compared to topical dilitazem and lignocaine alone in the management of anal fissures

Troikaa Pharmaceuticals Limited0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Adult patients aged between 18 - 60 years.
  • 2.Patients with a diagnosis of chronic anal fissure
  • 3.Patients with symptoms persisting after 2 weeks of standard management (diet, laxatives, Sitz-baths)

排除标准

  • 1.Patients having anal fistulas or anal fissure of various causes such as Crohn disease, anal suppuration, abscesses,
  • 2.Patients with associated acute haemorrhoidal attacks
  • 3.Patients having anal or perianal cancer
  • 4.Patients who have been surgically treated previously
  • 5.Pregnant women
  • 6.Patients of hypertension / IHD on oral CCBs.
  • 7.Known hypersensitivity to either dilitiazem or lignocaine
  • 8.Pregnant women /lactating mother
  • 9.Patients talking CCB, Nitrates, vasodilator
  • 10.Patients with HIV infection

研究者

相似试验